This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yu, W.-L.
Right arrow Articles by Jones, R. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, W.-L.
Right arrow Articles by Jones, R. N.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, January 2004, p. 362-363, Vol. 48, No. 1
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.1.362-364.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

LETTER TO THE EDITOR

Emergence of Two Klebsiella pneumoniae Isolates Harboring Plasmid-Mediated CTX-M-15 ß-Lactamase in Taiwan


arrow
LETTER
 
In recent years, cefotaximase (CTX-M)-type extended-spectrum ß-lactamase-producing Enterobacteriaceae has been increasingly discovered worldwide (7). These ß-lactamases confer a typical phenotype for which MICs of ceftriaxone and cefotaxime are higher than those of ceftazidime (7). In Taiwan, CTX-M-14 ß-lactamase has been found in Klebsiella pneumoniae (9), and CTX-M-3 enzyme has been discovered in Escherichia coli (8), K. pneumoniae (9), and Serratia marcescens (11). In this report, we described the first isolation of Taiwanese CTX-M-15-producing K. pneumoniae isolates for which MICs of ceftazidime were high (>=128 µg/ml).

Among 211 extended-spectrum ß-lactamase-producing K. pneumoniae isolates collected from the whole country between January 1998 and June 2000, two isolates (KPN 154, a urine isolate from hospital N03, and KPN 176, a blood isolate from hospital N04) containing an uncharacterized enzyme with a pI of 8.8 were studied. Both clinical isolates of K. pneumoniae were susceptible to imipenem (MIC, 0.12 µg/ml) and meropenem (MICs, 0.064 to 0.094 µg/ml) but were resistant to cefotaxime (MIC, >256 µg/ml), ceftazidime (MIC, 128 to >256 µg/ml), and cefepime (MIC, 32 to 64 µg/ml), as determined by using the E-test (Table 1). Clavulanic acid totally restored the activities of cefotaxime, ceftazidime, and cefepime to levels at which the isolates were susceptible (MICs, 0.047 to 2 µg/ml).


View this table:
[in this window]
[in a new window]
  		TABLE 1. Activity of various antimicrobial agentsa against two isolates of K. pneumoniae (KPN 154 and 176), two transconjugants (E154 and E176), and the recipient strain (E. coli J53-2) and their ribotypes, pIs, and bla gene characterization

Plasmid DNA templates were prepared and purified for PCR. Amplification was performed using PCR primers for the bla genes encoding TEMs, SHVs, or CTX-M-3 ß-lactamases (5, 9). Isoelectric focusing analysis revealed four enzymes with pIs of 5.4, 7.6, 8.2, and 8.8 in both isolates, which were matched to TEM-1, SHV-1, SHV-5, and CTX-M-15, respectively, by PCR and DNA sequence analysis (Table 1).

Automated ribotyping using the RiboPrinter Microbial Characterization system (Qualicon, Inc., Wilmington, Del.) revealed nonclonal relatedness of both K. pneumoniae strains, but each belonged to two different major clones in Taiwan (KPN 154, ribotype 255.3; KPN 176, ribotype 691.5).

Conjugation experiments provided evidence of transferable plasmids containing bla genes encoding SHV-5 (pI, 8.2) and/or CTX-M-15 (pI, 8.8). Both transconjugants revealed MIC profiles that were similar to those of the parent strains. The transconjugant E154 contained the gene blaCTX-M-15 without blaSHV-5, possibly indicating the failure of blaSHV-5 gene transference. Therefore, the presence of CTX-M-15 conferred to transconjugant E154 the ceftazidime resistance characterized in previous papers (1, 2, 6). This spectrum of hydrolysis has rarely been observed in other members of the CTX-M enzyme family (7). The mechanism of cefepime resistance may be the cumulative effects of CTX-M-15 and SHV-5 (as in KPN 154, KPN 176, and E176) or the presence of CTX-M-15 alone (as in E154).

CTX-M-15, an Asp-240-Gly variant of CTX-M-3, increased the catalytic efficiency against ceftazidime (6). CTX-M-15 ß-lactamase has already been identified in several countries, including India (2), Poland (1), Turkey (3), and the United Kingdom (4). Since CTX-M-15 differs from CTX-M-3 by only a single amino acid change and CTX-M-3 has also been widely disseminated among isolates of Enterobacteriaceae in Taiwan (8, 9, 11), it is not surprising that CTX-M-15 emerged in the Taiwan environment.

Although not clonally related, these two emerging CTX-M-15-producing strains were documented to evolve from different major K. pneumoniae clones in Taiwan. Ribotype 691.5 has been recognized as an epidemic clone in northern Taiwan, and ribotype 255.3 has been recognized as another nationwide-epidemic clone (10). Although still rare, strains producing CTX-M-15 in Taiwan could potentially further disseminate, either clonally or by plasmid-related transmission.


arrow
ACKNOWLEDGMENTS
 
We thank Diana L. Von Stein of the Veterans Affairs Medical Center in Iowa for technical assistance. We also thank Monto Ho of the National Health Research Institutes for providing strains from Taiwan.


arrow
REFERENCES
 
    1
  1. Baraniak, A., J. Fiett, W. Hryniewicz, P. Nordmann, and M. Gniadkowski. 2002. Ceftazidime-hydrolysing CTX-M-15 extended-spectrum ß-lactamase (ESBL) in Poland. J. Antimicrob. Chemother. 50:393-396.[Abstract/Free Full Text]
    2. 2
  2. Karim, A., L. Poirel, S. Nagarajan, and P. Nordmann. 2001. Plasmid-mediated extended-spectrum ß-lactamase (CTX-M-3 like) from India and gene association with insertion sequence ISEcp1. FEMS Microbiol. Lett. 201:237-241.[Medline]
    3. 3
  3. Lartique, M. F., L. Poirel, C. Heritier, V. Tolun, and P. Nordmann. 2003. First description of CTX-M-15-producing Klebsiella pneumoniae in Turkey. J. Antimicrob. Chemother. 52:315-316.[Free Full Text]
    4. 4
  4. Mushtaq, S., N. Woodford, N. Potz, and D. M. Livermore. 2003. Detection of CTX-M-15 extended-spectrum ß-lactamase in the United Kingdom. J. Antimicrob. Chemother. 52:528-529.[Free Full Text]
    5. 5
  5. Pai, H., S. Lyu, J. H. Lee, J. Kim, Y. Kwon, J. W. Kim, and K. W. Choe. 1999. Survey of extended-spectrum ß-lactamases in clinical isolates of Escherichia coli and Klebsiella pneumoniae: prevalence of TEM-52 in Korea. J. Clin. Microbiol. 37:1758-1763.[Abstract/Free Full Text]
    6. 6
  6. Poirel, L., M. Gniadkowski, and P. Nordmann. 2002. Biochemical analysis of the ceftazidime-hydrolysing extended-spectrum ß-lactamase CTX-M-15 and of its structurally related ß-lactamase CTX-M-3. J. Antimicrob. Chemother. 50:1031-1034.[Abstract/Free Full Text]
    7. 7
  7. Tzouvelekis, L. S., E. Tzelepi, P. T. Tassios, and N. J. Legakis. 2000. CTX-M-type beta-lactamases: an emerging group of extended-spectrum enzymes. Int. J. Antimicrob. Agents 14:137-142.[CrossRef][Medline]
    8. 8
  8. Yan, J. J., W. C. Ko, S. H. Tsai, H. M. Wu, Y. T. Jin, and J. J. Wu. 2000. Dissemination of CTX-M-3 and CMY-2 ß-lactamases among clinical isolates of Escherichia coli in southern Taiwan. J. Clin. Microbiol. 38:4320-4325.[Abstract/Free Full Text]
    9. 9
  9. Yu, W. L., P. L. Winokur, D. L. Von Stein, M. A. Pfaller, J. H. Wang, and R. N. Jones. 2002. First description of Klebsiella pneumoniae harboring CTX-M ß-lactamases (CTX-M-14 and CTX-M-3) in Taiwan. Antimicrob. Agents Chemother. 46:1098-1100.[Abstract/Free Full Text]
    10. 10
  10. Yu, W. L., R. N. Jones, R. J. Hollis, S. A. Messer, D. J. Biedenbach, L. M. Deshpande, and M. A. Pfaller. 2002. Molecular epidemiology of extended-spectrum ß-lactamase-producing, fluoroquinolone-resistant isolates of Klebsiella pneumoniae in Taiwan. J. Clin. Microbiol. 40:4666-4669.[Abstract/Free Full Text]
    11. 11
  11. Yu, W. L., L. T. Wu, P. L. Winokur, M. A. Pfaller, and R. N. Jones. 2003. Confirmation of extended-spectrum ß-lactamase-producing Serratia marcescens: preliminary report in Taiwan. Diagn. Microbiol. Infect. Dis. 45:221-224.[CrossRef][Medline]
Wen-Liang Yu*
Kuo-Chen Cheng
Department of Critical Care Medicine
Chi-Mei Medical Center
901 Chung Hwa Rd.
710 Yung Kang, Taiwan

Lii-Tzu Wu
China Medical University
Taichung, Taiwan

Michael A. Pfaller
Patricia L. Winokur
University of Iowa College of Medicine
Iowa City, Iowa

Ronald N. Jones
The JONES GROUP/JMI Laboratories
North Liberty, Iowa

* Phone: 886-6-2812811, ext. 2605, Fax: 886-6-2833351, E-mail: yuleon_md{at}yahoo.com.tw

Antimicrobial Agents and Chemotherapy, January 2004, p. 362-363, Vol. 48, No. 1
0066-4804/04/$08.00+0     DOI: 10.1128/AAC.48.1.362-364.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Wu, L.-T., Chang, S.-Y., Yen, M.-R., Yang, T.-C., Tseng, Y.-H. (2007). Characterization of Extended-Host-Range Pseudo-T-Even Bacteriophage Kpp95 Isolated on Klebsiella pneumoniae. Appl. Environ. Microbiol. 73: 2532-2540 [Abstract] [Full Text]  
  • Ensor, V. M., Livermore, D. M., Hawkey, P. M. (2007). A novel reverse-line hybridization assay for identifying genotypes of CTX-M-type extended-spectrum {beta}-lactamases. J Antimicrob Chemother 59: 387-395 [Abstract] [Full Text]  
  • Moubareck, C., Daoud, Z., Hakime, N. I., Hamze, M., Mangeney, N., Matta, H., Mokhbat, J. E., Rohban, R., Sarkis, D. K., Doucet-Populaire, F. (2005). Countrywide Spread of Community- and Hospital-Acquired Extended-Spectrum {beta}-Lactamase (CTX-M-15)-Producing Enterobacteriaceae in Lebanon. J. Clin. Microbiol. 43: 3309-3313 [Abstract] [Full Text]  
  • Ho, P. L., Ho, A. Y. M., Chow, K. H., Wong, R. C. W., Duan, R. S., Ho, W. L., Mak, G. C., Tsang, K. W., Yam, W. C., Yuen, K. Y. (2005). Occurrence and molecular analysis of extended-spectrum {beta}-lactamase-producing Proteus mirabilis in Hong Kong, 1999-2002. J Antimicrob Chemother 55: 840-845 [Abstract] [Full Text]  
  • Gangoue-Pieboji, J., Miriagou, V., Vourli, S., Tzelepi, E., Ngassam, P., Tzouvelekis, L. S. (2005). Emergence of CTX-M-15-Producing Enterobacteria in Cameroon and Characterization of a blaCTX-M-15-Carrying Element. Antimicrob. Agents Chemother. 49: 441-443 [Abstract] [Full Text]  
  • Conceicao, T., Brizio, A., Duarte, A., Lito, L. M., Cristino, J. M., Salgado, M. J. (2005). First Description of CTX-M-15-Producing Klebsiella pneumoniae in Portugal. Antimicrob. Agents Chemother. 49: 477-478 [Full Text]  
  • Pallecchi, L., Malossi, M., Mantella, A., Gotuzzo, E., Trigoso, C., Bartoloni, A., Paradisi, F., Kronvall, G., Rossolini, G. M. (2004). Detection of CTX-M-Type {beta}-Lactamase Genes in Fecal Escherichia coli Isolates from Healthy Children in Bolivia and Peru. Antimicrob. Agents Chemother. 48: 4556-4561 [Abstract] [Full Text]  

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yu, W.-L.
Right arrow Articles by Jones, R. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, W.-L.
Right arrow Articles by Jones, R. N.

Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»